Andrew Slimmon, Morgan Stanley Investment Management senior portfolio manager, joins 'Squawk Box' to discuss the latest ...
Fintel reports that on December 9, 2024, Morgan Stanley downgraded their outlook for Lazard (NYSE:LAZ) from Overweight to ...
The S&P 500 has delivered a median return of +1.5% during this month over the past 45 years, with positive results occurring ...
In a report released today, Betsy Graseck from Morgan Stanley maintained a Buy rating on Goldman Sachs Group (GS – Research Report), with a ...
Morgan Stanley analyst Ryan Kenny upgraded Moelis (MC) to Overweight from Underweight with a price target of $92, up from $66. After this ...
Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...
We recently compiled a list of the Morgan Stanley’s Best Stocks For Economic Recovery: Top 9 Cyclical Stocks. In this article ...
Investing.com-- Foreign investment in Chinese equities reversed course in November, marking the end of a brief two-month ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.62, a high estimate of $142 ...
It’s extremely difficult to predict short-term moves in the market with any accuracy. But the research, analysis, and ...